Sanofi

Sanofi Announces Ambitious $1 Billion Investment to Enhance Manufacturing Capabilities in China

20 days ago

In a significant move aimed at boosting its production capabilities, French pharmaceutical giant Sanofi has unveiled plans for a substantial $1 billion investment in China. This initiative is designed to enhance the company's manufacturing footprint within one of the world's most dynamic markets, further solidifying its operational base in Asia.

CD&R Takes Strategic Steps to Alleviate French Concerns Over Sanofi Acquisition

2 months ago

In a proactive effort to address rising concerns from the French government regarding its acquisition of Sanofi, private equity firm Clayton, Dubilier & Rice (CD&R) is reportedly preparing to implement measures aimed at easing these apprehensions. The initiatives come as the proposed purchase of the French pharmaceutical giant by CD&R has stirred significant trepidation among stakeholders in France, particularly in light of the country's focus on safeguarding its strategic industries.

France Contemplates State Stake in Sanofi’s Asset Sale to CD&R

2 months ago

In a pivotal move that could redefine the landscape of France's healthcare sector, the French government is considering acquiring a stake in a Sanofi subsidiary that is currently set to be sold to the private equity firm Clayton, Dubilier & Rice (CD&R). This potential stake acquisition comes as Sanofi, a leading global biopharmaceutical company, seeks to divest certain assets to focus on its core operations and enhance its strategic initiatives.